How it Works
Admera Health has developed a streamlined process for requesting collection supplies, sample submission, and reviving actionable patient specific reports.
How it works
Admera Health has developed a streamlined process for requesting collection supplies, sample submission, and reviving actionable patient specific reports
Multiple Sample Types
Admera offers multiple sample collection supply types, making it easy to find a method that best works for physician’s and their patients. For high volume practices, an auto replenish program is available to ensure your practice never runs out of supplies.
Multiple Sample Types
Admera offers multiple sample collection supply types, making it easy to find a method that best works for physician’s and their patients. For high volume practices, an auto replenish program is available to ensure your practice never runs out of supplies.
Requisition and Informed Consent
A completed requisition, patient’s medical history, medication list, and signature from both the referring physician and patient on the Informed Consent needs to be included with the sample.
Requisition and Informed Consent
A completed requisition, patient’s medical history, medication list, and signature from both the referring physician and patient on the Informed Consent needs to be included with the sample.
The Admera Health Difference
Convenient
Overnight Delivery
Admera provides prepaid pre-addressed envelops for overnight delivery of samples to laboratory
Upon Sample Delivery Admera Health will…
Isolate DNA (RNA too, for cancer targeted therapy selection tests)
Perform Next Generation Sequencing or proprietary qPCR for some LiquidGx™ tests
Actionable
Report Delivery
User friendly reports for Pharmacogenomics, Oncology and Cardiovascular Test Portfolio, and Solid Tumor Profiling
The Admera Health Difference
Convenient
Overnight Delivery
Admera provides prepaid pre-addressed envelops for overnight delivery of samples to laboratory
Upon Sample Delivery Admera Health will…
Isolate DNA(RNA too, for cancer targeted therapy selection tests)
Perform Next Generation Sequencing or proprietary qPCR for some LiquigGxTM tests
Actionable
Report Delivery
User friendly reports for Pharmacogenomics, Oncology and Cardiovascular Test Portfolio, and Solid Tumor Profiling
Actionable Report Delivery
Pharmacogenomics
Receive an actionable report in 7-10 business days
All Admera PGx tests include recommendations on over 300 drugs and sections driven by diagnosis codes & current medications.
Pharmacogenomics Test Report Options:
Comprehensive reports with
specific sections driven by
patients diagnosis codes and
current medications
Comprehensive specialty report highlighting psychiatric drugs with favorable recommendations in the first section of the report
Comprehensive specialty report with specific sections for drugs commonly used in cancer supportive care and chemotherapeutics
Comprehensive report
for optimizing
cardiovascular
drug therapy
Pharmacogenomics Test Report Options:
Comprehensive reports with
specific sections driven by
patients diagnosis codes
and current medications
Comprehensive specialty report highlighting psychiatric drugs with favorable recommendations in the first section of the report
Comprehensive specialty report with specific sections for drugs commonly used in cancer supportive care and chemotherapeutics
Comprehensive report
for optimizing
cardiovascular
drug therapy
Oncology Test Portfolio
Receive an actionable report for selecting targeting therapies and treatment monitering from a blood sample in < 3 and 3-5 business days for qPCR and NGS respectively.
Actionable reports for targeted therapy selection, prognosis, and multivariant analysis will be delivered within 7-10 business days.
Actionable reports for targeted therapy selection, prognosis, and multivariant analysis will be delivered within 7-10 business days.
Cardiovascular Test Portfolio
Receive reports for risk assessment and diagnosis of inherited cardiovascular diseases within 3-4 weeks.
Cardiovascular Test Portfolio
Receive reports for risk assessment and diagnosis of inherited cardiovascular diseases within 3-4 weeks.